The company manufactures and exports leather footwear and finished leather, operating integrated tanneries and factories to supply global retailers and its own brands like Thomas Crick and Off the Hook.
While the company claims a brand-led moat, the financials show a significant decline in revenue and earnings, suggesting the brands lack pricing power. The integrated manufacturing provides a cost-efficiency mechanism, but it has not protected the bottom line from severe erosion.
Capital has been deployed into vertical integration and brand launches, but the resulting returns on equity and capital are weak. The company recently completed a merger with a subsidiary and is proposing a complex restructuring to segregate business verticals.
The investment collapsed as the complex restructuring and demerger failed to unlock value, instead creating a labyrinth of related-party transactions that obscured a deteriorating core business. The Income Tax Department's investigation likely uncovered systemic irregularities, leading to heavy penalties and a permanent loss of institutional trust. As revenue continued its double-digit decline, the lack of pricing power in a commoditized footwear market forced margins toward zero, while the high promoter remuneration and frequent management turnover signaled a leadership more interested in extraction than stewardship.
RichFakir rates Mirza International Ltd's business quality as poor — 24/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Mirza International Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Mirza International Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Mirza International Ltd's fair value is about ₹7 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →